{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:33:23Z","timestamp":1794047603845,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02906-y","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:45:45Z","timestamp":1756363545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Breakthrough hepatitis B virus infection and its associated factors among vaccinated children in Northwest Ethiopia"],"prefix":"10.1038","volume":"15","author":[{"given":"Mekuanint","family":"Geta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimtubezinash","family":"Woldeamanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"11","key":"2906_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMsa050467","volume":"353","author":"J He","year":"2005","unstructured":"He, J. et al. Major causes of death among men and women in China. N Engl. J. Med. 353 (11), 1124\u20131134 (2005).","journal-title":"N Engl. J. Med."},{"key":"2906_CR2","unstructured":"World Health Organization. Hepatitis B. Fact sheet. July (2021)."},{"issue":"1","key":"2906_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","volume":"64","author":"C Seeger","year":"2000","unstructured":"Seeger, C. & Mason, W. S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64 (1), 51 (2000).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2906_CR4","unstructured":"World Health Organization. Hepatitis B in the WHO European Region (July, 2017)."},{"issue":"2","key":"2906_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpge.2015.01.009","volume":"22","author":"MJ Magalh\u00e3es","year":"2015","unstructured":"Magalh\u00e3es, M. J. & Pedroto, I. Hepatitis B virus inactive carriers: which follow-up strategy? GE Port J. Gastroenterol. 22 (2), 47\u201351 (2015).","journal-title":"GE Port J. Gastroenterol."},{"issue":"1","key":"2906_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard, C. W., Simard, E. P., Finelli, L., Fiore, A. E. & Bell, B. P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28 (1), 112\u2013125 (2006).","journal-title":"Epidemiol. Rev."},{"issue":"6","key":"2906_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer, D. et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3 (6), 383\u2013403 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"2906_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11093-0","volume":"21","author":"C Freeland","year":"2021","unstructured":"Freeland, C. et al. Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study. BMC Public. Health. 21 (1), 1\u20138 (2021).","journal-title":"BMC Public. Health"},{"issue":"4","key":"2906_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12072-018-9884-8","volume":"12","author":"D Ginzberg","year":"2018","unstructured":"Ginzberg, D., Wong, R. J., Gish, R. & Global HBV burden: guesstimates and facts. Hepatol. Int. 12 (4), 315\u2013329 (2018).","journal-title":"Hepatol. Int."},{"issue":"42","key":"2906_CR10","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3748\/wjg.v21.i42.11941","volume":"21","author":"R Zampino","year":"2015","unstructured":"Zampino, R. et al. Hepatitis B virus burden in developing countries. World J. Gastroenterol. 21 (42), 11941\u201311953 (2015).","journal-title":"World J. Gastroenterol."},{"key":"2906_CR11","unstructured":"World Health Organization. Hepatitis: Preventing mother-to-child transmission of the hepatitis B virus. 27 July 2020. https:\/\/www.who.int\/publications\/i\/item\/978-92-4-000270-8"},{"key":"2906_CR12","unstructured":"World Health Organization. Global Hepatitis Report. Geneva. (2017). https:\/\/www.who.int\/publications\/i\/item\/9789241565455"},{"key":"2906_CR13","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. Accountability for the global health sector strategies 2016\u20132021: actions for impact. Geneva. (2021)."},{"key":"2906_CR14","unstructured":"World Health Organization. Global hepatitis program. Hepatitis B vaccination and prevention of mother-to-child transmission. (2017). https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hepatitis\/prevention\/mother-to-child-transmission-of-hepatitis-b"},{"issue":"2","key":"2906_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/ije\/dyaa253","volume":"50","author":"N Schmit","year":"2021","unstructured":"Schmit, N., Nayagam, S., Thursz, M. R. & Hallett, T. B. The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups. Int. J. Epidemiol. 50 (2), 560\u2013569 (2021).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"2906_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","volume":"132","author":"YH Ni","year":"2007","unstructured":"Ni, Y. H. et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132 (4), 1287\u20131293 (2007).","journal-title":"Gastroenterology"},{"key":"2906_CR17","first-page":"e7926","volume":"12","author":"I Seerat","year":"2020","unstructured":"Seerat, I., Mushtaq, H., Rafiq, M. & Nadir, A. Frequency and associated risk factors of hepatitis B virus and hepatitis C virus infections in children at a hepatitis prevention and treatment clinic in Lahore, Pakistan. Cureus 12, e7926 (2020).","journal-title":"Cureus"},{"key":"2906_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00006454-199905000-00006","volume":"18","author":"HH Shih","year":"1999","unstructured":"Shih, H. H. et al. Long term immune response of universal hepatitis B vaccination in infancy: A community-based study in Taiwan. Pediatr. Infect. Dis. J. 18, 427\u2013432 (1999).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2906_CR19","doi-asserted-by":"publisher","first-page":"e0194285","DOI":"10.1371\/journal.pone.0194285","volume":"13","author":"JM Mba","year":"2018","unstructured":"Mba, J. M. et al. Prevalent hepatitis B surface antigen among first-time blood donors in Gabon. PLoS One. 13, e0194285 (2018).","journal-title":"PLoS One"},{"key":"2906_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1186\/s12879-019-4486-1","volume":"19","author":"TD Yazie","year":"2019","unstructured":"Yazie, T. D. & Tebeje, M. G. An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia. BMC Infect. Dis. 19, 917 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"Suppl.S2","key":"2906_CR21","first-page":"167","volume":"57","author":"S Teshome","year":"2019","unstructured":"Teshome, S. et al. Antibody response against hepatitis B virus after vaccination and Seroprevalence of hepatitis B virus in children in addis Ababa, Ethiopia. Ethiop. Med. J. 57 (Suppl.S2), 167\u2013173 (2019).","journal-title":"Ethiop. Med. J."},{"issue":"Suppl","key":"2906_CR22","first-page":"1","volume":"57","author":"S Usman","year":"2019","unstructured":"Usman, S. et al. Serum level of anti-hepatitis B surface antigen and associated factors among vaccinated and unvaccinated children in Harar, Eastern Ethiopia: A community-based study. Ethiop. Med. J. 57 (Suppl), 1\u20137 (2019).","journal-title":"Ethiop. Med. J."},{"issue":"Suppl. S2","key":"2906_CR23","first-page":"147","volume":"57","author":"R Kedir","year":"2019","unstructured":"Kedir, R. et al. Seroprevalence of hepatitis B infection and seroprotection of hepatitis B vaccine among children in Jimma town, Southwest Ethiopia. Ethiop. Med. J. 57 (Suppl. S2), 147\u2013158 (2019).","journal-title":"Ethiop. Med. J."},{"issue":"Suppl. S2","key":"2906_CR24","first-page":"139","volume":"57","author":"G Ayalew","year":"2019","unstructured":"Ayalew, G. et al. Immune protection of hepatitis B vaccine among children in Gondar, Northwest Ethiopia. Ethiop. Med. J. 57 (Suppl. S2), 139\u2013146 (2019).","journal-title":"Ethiop. Med. J."},{"key":"2906_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12879-020-05229-7","volume":"20","author":"B Argaw","year":"2020","unstructured":"Argaw, B. et al. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, Southern Ethiopia. BMC Infect. Dis. 20, 528 (2020).","journal-title":"BMC Infect. Dis."},{"key":"2906_CR26","doi-asserted-by":"publisher","first-page":"1234620","DOI":"10.3389\/frsc.2023.1234620","volume":"5","author":"DT Adigeh","year":"2024","unstructured":"Adigeh, D. T. & Abebe, B. G. Land acquisition policy and practice for cooperative housing scheme in Bahir Dar, Ethiopia: toward affordable housing solutions. Frontier Sustain. Cities. 5, 1234620 (2024).","journal-title":"Frontier Sustain. Cities"},{"issue":"3","key":"2906_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3851\/IMP1555","volume":"15","author":"MH Chang","year":"2010","unstructured":"Chang, M. H. Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther. 15 (3), 463 (2010).","journal-title":"Antivir Ther."},{"issue":"6","key":"2906_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi, G. et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol. Hepatol. 4 (6), 466\u2013476 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2906_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0168-8278(03)00141-7","volume":"39","author":"MJ Alter","year":"2003","unstructured":"Alter, M. J. Epidemiology of hepatitis B in Europe and worldwide. J. Hepatol. 39, 64\u201369 (2003).","journal-title":"J. Hepatol."},{"issue":"7","key":"2906_CR30","doi-asserted-by":"publisher","first-page":"e0288355","DOI":"10.1371\/journal.pone.0288355","volume":"18","author":"A Adugna","year":"2023","unstructured":"Adugna, A. et al. Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia. Plos One. 18 (7), e0288355 (2023).","journal-title":"Plos One"},{"issue":"1","key":"2906_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/children11010136","volume":"11","author":"T Alemayehu","year":"2024","unstructured":"Alemayehu, T., Daba, M. D. & Buonsenso, D. Long-term hepatitis B vaccine immunity in Ethiopian children that received a pentavalent vaccine series: A retrospective cohort study. Children 11 (1), 136 (2024).","journal-title":"Children"},{"issue":"2","key":"2906_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/01.MJX.0000457179.97263.b7","volume":"13","author":"SM Sami","year":"2014","unstructured":"Sami, S. M. et al. infection, seroprotection, and anamnestic response among children vaccinated during infancy in Beni-Suef, Egypt. Med. Res. J. 13 (2), 86\u201392 (2014).","journal-title":"Med. Res. J."},{"issue":"2","key":"2906_CR33","first-page":"721","volume":"9","author":"OC Hagan","year":"2018","unstructured":"Hagan, O. C. et al. Impact of universal childhood vaccination against hepatitis B in Ghana: A pilot study. J. Pub Health Afr. 9 (2), 721 (2018).","journal-title":"J. Pub Health Afr."},{"issue":"4","key":"2906_CR34","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.4081\/pr.2019.8248","volume":"11","author":"M Barro","year":"2019","unstructured":"Barro, M. et al. Serological profile of hepatitis B in children after the introduction of its vaccination in Burkina Faso. Pediatr. Rep. 11 (4), 8248 (2019).","journal-title":"Pediatr. Rep."},{"issue":"Supplement_4","key":"2906_CR35","doi-asserted-by":"publisher","first-page":"ckz185","DOI":"10.1093\/eurpub\/ckz185.592","volume":"29","author":"L Perieres","year":"2019","unstructured":"Perieres, L. et al. Hepatitis B vaccination status and vaccine immune response among children in rural Senegal. Eur. J. Public. Health. 29 (Supplement_4), ckz185\u2013592 (2019).","journal-title":"Eur. J. Public. Health"},{"issue":"1","key":"2906_CR36","first-page":"140","volume":"32","author":"G L\u00f4","year":"2019","unstructured":"L\u00f4, G. et al. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level. Pan Afr. Med. J. 32 (1), 140 (2019).","journal-title":"Pan Afr. Med. J."},{"issue":"2","key":"2906_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2105\/AJPH.2011.300239","volume":"102","author":"ML B\u00f8rresen","year":"2012","unstructured":"B\u00f8rresen, M. L. et al. Effectiveness of the targeted hepatitis B vaccination program in Greenland. Am. J. Public. Health. 102 (2), 277\u2013284 (2012).","journal-title":"Am. J. Public. Health"},{"issue":"2","key":"2906_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.vaccine.2013.11.004","volume":"32","author":"TH Nguyen","year":"2014","unstructured":"Nguyen, T. H. et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine 32 (2), 217\u2013222 (2014).","journal-title":"Vaccine"},{"issue":"10","key":"2906_CR39","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/j.1365-3156.2006.01709.x","volume":"11","author":"V Chongsrisawat","year":"2006","unstructured":"Chongsrisawat, V. et al. Hepatitis B Seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the National expanded programme on immunization. Trop. Med. Int. Health. 11 (10), 1496\u20131502 (2006).","journal-title":"Trop. Med. Int. Health"},{"issue":"6","key":"2906_CR40","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1080\/21645515.2020.1847951","volume":"17","author":"X Zhao","year":"2021","unstructured":"Zhao, X., Shi, X., Lv, M., Yuan, B. & Wu, J. Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing. Hum. Vaccin Immunother. 17 (6), 1818\u20131824 (2021).","journal-title":"Hum. Vaccin Immunother"},{"key":"2906_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijid.2018.01.027","volume":"71","author":"Q Zhu","year":"2018","unstructured":"Zhu, Q. et al. Epidemiological serosurvey of hepatitis B virus among children aged 1\u201314 years in Guangdong Province, China. Int. J. Infect. Dis. 71, 25\u201329 (2018).","journal-title":"Int. J. Infect. Dis."},{"issue":"47","key":"2906_CR42","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","volume":"27","author":"X Liang","year":"2009","unstructured":"Liang, X. et al. Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination. Vaccine 27 (47), 6550\u20136557 (2009).","journal-title":"Vaccine"},{"key":"2906_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-12-272","volume":"12","author":"X Li","year":"2012","unstructured":"Li, X. et al. Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study. BMC Public. Health. 12, 1\u20137 (2012).","journal-title":"BMC Public. Health"},{"issue":"8","key":"2906_CR44","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/liv.15959","volume":"44","author":"KC Chang","year":"2024","unstructured":"Chang, K. C. et al. Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan. Liver Int. 44 (8), 2054\u20132062 (2024).","journal-title":"Liver Int."},{"issue":"22","key":"2906_CR45","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.4254\/wjh.v7.i22.2418","volume":"7","author":"II Salama","year":"2015","unstructured":"Salama, I. I. et al. Effectiveness of hepatitis B virus vaccination program in Egypt: multicenter National project. World J. Hepatol. 7 (22), 2418 (2015).","journal-title":"World J. Hepatol."},{"issue":"1","key":"2906_CR46","first-page":"13","volume":"21","author":"ATA Hamid","year":"2014","unstructured":"Hamid, A. T. A. & Said, Z. N. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya-Egypt. Egypt. J. Immunol. 21 (1), 13\u201326 (2014).","journal-title":"Egypt. J. Immunol."},{"issue":"5\u20136","key":"2906_CR47","first-page":"495","volume":"80","author":"H Shatat","year":"2005","unstructured":"Shatat, H., Kotkat, A., Farghaly, A., Omar, S. & Zayton, S. A study of hepatitis B vaccine efficacy 10 years after compulsory vaccination in Egypt. J. Egypt. Public. Health Assoc. 80 (5\u20136), 495\u2013508 (2005).","journal-title":"J. Egypt. Public. Health Assoc."},{"issue":"1","key":"2906_CR48","first-page":"1","volume":"10","author":"I Okonko","year":"2012","unstructured":"Okonko, I., Okerentugba, P. & Innocient-Adiele, H. Detection of hepatitis B surface antigen (HBSAg) among children in Ibadan, Southwestern Nigeria. Int. J. Infect. Dis. 10 (1), 1\u20137 (2012).","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"2906_CR49","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1086\/323396","volume":"184","author":"A Mele","year":"2001","unstructured":"Mele, A. et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J. Infect. Dis. 184 (7), 905\u2013908 (2001).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"2906_CR50","first-page":"45","volume":"12","author":"S Hashemi","year":"2010","unstructured":"Hashemi, S., Moghadami, M., Bagheri, L. K., Alborzi, A. & Mahboudi, A. The efficacy of hepatitis B vaccination among school age children in Southern Iran. Iran. Red Crescent Med. J. 12 (1), 45\u201348 (2010).","journal-title":"Iran. Red Crescent Med. J."},{"issue":"2","key":"2906_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jmv.21035","volume":"80","author":"D Avazova","year":"2008","unstructured":"Avazova, D. et al. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan. J. Med. Virol. 80 (2), 217\u2013224 (2008).","journal-title":"J. Med. Virol."},{"issue":"18","key":"2906_CR52","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.vaccine.2018.03.044","volume":"36","author":"X Li","year":"2018","unstructured":"Li, X. et al. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0-to 8-year-old children: protective anti-HBs levels and cellular immune responses. Vaccine 36 (18), 2442\u20132449 (2018).","journal-title":"Vaccine"},{"issue":"4","key":"2906_CR53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jmv.23496","volume":"85","author":"LW Ang","year":"2013","unstructured":"Ang, L. W., Tey, S. H., Cutter, J., James, L. & Goh, K. T. Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008\u20132010. J. Med. Virol. 85 (4), 583\u2013588 (2013).","journal-title":"J. Med. Virol."},{"issue":"1","key":"2906_CR54","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1017\/S0950268803008574","volume":"131","author":"A Abebe","year":"2003","unstructured":"Abebe, A. et al. Seroepidemiology of hepatitis B virus in addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol. Infect. 131 (1), 757\u2013770 (2003).","journal-title":"Epidemiol. Infect."},{"issue":"3","key":"2906_CR55","doi-asserted-by":"publisher","first-page":"e58029","DOI":"10.1371\/journal.pone.0058029","volume":"8","author":"M Mendy","year":"2013","unstructured":"Mendy, M. et al. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PloS One. 8 (3), e58029 (2013).","journal-title":"PloS One"},{"issue":"5","key":"2906_CR56","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijerph20054142","volume":"20","author":"DB Fofana","year":"2023","unstructured":"Fofana, D. B. et al. Hepatitis B virus in West African children: systematic review and meta-analysis of HIV and other factors associated with hepatitis B infection. Int. J. Environ. Res. Public. Health. 20 (5), 4142 (2023).","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"6","key":"2906_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4254\/wjh.v3.i6.147","volume":"3","author":"EA Abushady","year":"2011","unstructured":"Abushady, E. A. et al. HBV vaccine efficacy and detection and genotyping of vaccinee asymptomatic breakthrough HBV infection in Egypt. World J. Hepatol. 3 (6), 147 (2011).","journal-title":"World J. Hepatol."},{"issue":"19","key":"2906_CR58","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1016\/j.vaccine.2022.03.049","volume":"40","author":"L Breakwell","year":"2022","unstructured":"Breakwell, L. et al. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018. Vaccine 40 (19), 2741\u20132748 (2022).","journal-title":"Vaccine"},{"key":"2906_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2763-4","volume":"17","author":"PR Shedain","year":"2017","unstructured":"Shedain, P. R., Devkota, M. D., Banjara, M. R., Ling, H. & Dhital, S. Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal. BMC Infect. Dis. 17, 1\u20139 (2017).","journal-title":"BMC Infect. Dis."},{"key":"2906_CR60","unstructured":"Bezerra, J. A., Mack, C. L. & Shneider, B. L. in Liver Disease in Children. i\u2013ii (eds Suchy, F. J., Sokol, R. J. & Balistreri, W. F.) (Cambridge University Press, 2021)."},{"issue":"1","key":"2906_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jceh.2017.12.001","volume":"8","author":"A Arora","year":"2018","unstructured":"Arora, A. et al. INASL position statements on prevention, diagnosis and management of hepatitis B virus infection in India: the Andaman statements. J. Clin. Exp. Hepatol. 8 (1), 58\u201380 (2018).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"2906_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/HMER.S407069","volume":"15","author":"D Weldebrhan","year":"2023","unstructured":"Weldebrhan, D., Berhe, H. & Tesfay, Y. Risk factors for hepatitis B virus infection in North Ethiopia: A case\u2013control study. Hepat. Med: Evid. Res. 15, 79\u201391 (2023).","journal-title":"Hepat. Med: Evid. Res."},{"issue":"4","key":"2906_CR63","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.5001\/omj.2021.99","volume":"36","author":"SA Al-Busafi","year":"2021","unstructured":"Al-Busafi, S. A., Al-Harthi, R., Al-Naamani, K., Al-Zuhaibi, H. & Priest, P. Risk factors for hepatitis B virus transmission in Oman. Oman Med. J. 36 (4), e287 (2021).","journal-title":"Oman Med. J."},{"issue":"7","key":"2906_CR64","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jiph.2023.05.003","volume":"16","author":"S Athalye","year":"2023","unstructured":"Athalye, S. et al. Exploring risk factors and transmission dynamics of hepatitis B infection among Indian families: implications and perspective. J. Infect. Public. Health. 16 (7), 1109\u20131114 (2023).","journal-title":"J. Infect. Public. Health"},{"key":"2906_CR65","first-page":"100605","volume":"22","author":"S Anticoli","year":"2025","unstructured":"Anticoli, S. et al. Sex differences in response to HBV vaccination in a cohort of health care workers. Vaccine: X. 22, 100605 (2025).","journal-title":"Vaccine: X"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02906-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02906-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02906-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:56:55Z","timestamp":1757451415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02906-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02906-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol received approval from the scientific and ethical review committee of CDT-Africa and the Institutional Review Board of the College of Health Sciences, Addis Ababa University, Ethiopia. Informed consent was obtained from all participants and their legal guardians. The research poses no more than minimal risks to participants. The study complied with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations and consent to participate"}}],"article-number":"31704"}}